Agentic AI could reshape drug development. In this interview, Dr. Claudio D’Ambrosio discusses how agentic AI can identify novel drug compounds, improve trial design, and reduce operational ...

The U.S. Senate has a plan to improve drug development for rare disease patients. The exit of controversial CBER chief Vinay Prasad will help clear the path.

Understand the impact of IND delays on biotechnology companies and how they affect early-stage development and funding.

As sponsors advanced more niche and personalized modalities, manufacturers were pushed to adopt holistic approaches to safety ...

Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.

Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...

Find out how self-driving labs utilise data-driven approaches to enhance drug discovery efficiency and innovation.

Many biological functions are regulated by the switching on and off of mechanisms triggered by the matching of a keyhole ...

New FDA guidelines for personalized genomic drug development are a step forward in advancing new therapies for ultrarare diseases, but industry leaders need further clarification.

Creating a drug that might help treat or cure a health condition in humans is a long, complex process. After developing a candidate drug that shows potential—a process that, in and of itself, can take ...

FDA plans to drop the de facto two-pivotal-trial expectation, requiring one adequate and well-controlled study plus confirmatory evidence to support approval. Scientific justification centers on ...

Explore drug rehab centers in Atlanta offering comprehensive addiction treatment, detox programs, therapy, and long-term recovery support to help individuals overcome substance abuse and ...